Upregulation of plasmacytoid dendritic cells in glioma

Tumor Biology

Volumn 35, Issue 10, 2014, Pages 9661-9666

  Wang, Rui ^a   Zhang, Ju Liang ^b   Wei, Bo ^a   Tian, Yu ^a   Li, Zhao Hui ^a   Wang, Le ^a   Du, Chao ^a  

^a CHINA JAPAN UNION HOSPITAL OF JILIN UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Aphasia; Glioma; Plasmacytoid dendritic cells

Indexed keywords

BRAIN TUMOR; DENDRITIC CELL; FEMALE; FLOW CYTOMETRY; GLIOMA; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; PATHOLOGY; UPREGULATION;

BRAIN NEOPLASMS; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; GLIOMA; HUMANS; MALE; MIDDLE AGED; UP-REGULATION;

EID: 84922392767     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13277-014-2211-7     Document Type: Article

References (24)

1. Han S, Feng S, Yuan G, Dong T, Gao D, et al. Lysyl oxidase genetic variants and the prognosis of glioma. APMIS. 2014;122:200–5.
2. Bashir T, Cloninger C, Artinian N, Anderson L, Bernath A, et al. Conditional astroglial Rictor overexpression induces malignant glioma in mice. PLoS One. 2012;7:e47741.
3. Robinson JP, VanBrocklin MW, Guilbeault AR, Signorelli DL, Brandner S, et al. Activated BRAF induces gliomas in mice when combined with Ink4a/Arf loss or Akt activation. Oncogene. 2010;29:335–44.
4. Zen M, Canova M, Campana C, Bettio S, Nalotto L, et al. The kaleidoscope of glucocorticoid effects on immune system. Autoimmun Rev. 2011;10:305–10.
5. Zhang HG, Grizzle WE. Exosomes and cancer: a newly described pathway of immune suppression. Clin Cancer Res. 2011;17:959–64.
6. Yu XH, Jiang N, Zheng XL, Cayabyab FS, Tang ZB, et al. Interleukin-17A in lipid metabolism and atherosclerosis. Clin Chim Acta. 2014;431C:33–9.
7. Yuan X, Wei Q, Komaki R, Liu Z, Yang J, et al. Polymorphisms predict distant metastasis-free survival in patients with inoperable non-small-cell lung cancer after definitive radiotherapy. PLoS One. 2013;8:e65659.
8. Yang S, Wang C, Zhou Y, Sun G, Zhu D, et al. Cytotoxic T-lymphocyte antigen-4 polymorphisms and susceptibility to Ewing’s sarcoma. Genet Test Mol Biomark. 2012;16:1236–40.
9. Yu H, Zou X, Peng L, Wang Y, Zhang C, et al. Effect of soluble inducible costimulator level and its polymorphisms on age-related macular degeneration. DNA Cell Biol. 2013;32:717–21.
10. Xiang H, Zhao W, Sun Y, Qian W, Xing J, et al. CD86 gene variants and susceptibility to pancreatic cancer. J Cancer Res Clin Oncol. 2012;138:2061–7.
11. Xu P, Chen YJ, Chen H, Zhu XY, Song HF, et al. The expression of programmed death-1 in circulating CD4+ and CD8+ T cells during hepatitis B virus infection progression and its correlation with clinical baseline characteristics. Gut Liver. 2014;8:186–95.
12. Yamahira A, Narita M, Nakamura T, Watanabe N, Kaji M, et al. Generation of antigen-specific cytotoxic T lymphocytes using a leukemic plasmacytoid dendritic cell line as antigen presenting cells. Leuk Res. 2011;35:793–9.
13. Wei L, Liu B, Tuo J, Shen D, Chen P, et al. Hypomethylation of the IL17RC promoter associates with age-related macular degeneration. Cell Rep. 2012;2:1151–8.
14. Wendland M, Willenzon S, Kocks J, Davalos-Misslitz AC, Hammerschmidt SI, et al. Lymph node T cell homeostasis relies on steady state homing of dendritic cells. Immunity. 2011;35:945–57.
15. Wergeland I, Assmus J, Dyrhol-Riise AM. T regulatory cells and immune activation in Mycobacterium tuberculosis infection and the effect of preventive therapy. Scand J Immunol. 2011;73:234–42.
16. Adachi K, Davis MM. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells. Proc Natl Acad Sci U S A. 2011;108:1549–54.
17. Ait-Oufella H, Sage AP, Mallat Z, Tedgui A. Adaptive (T and B cells) immunity and control by dendritic cells in atherosclerosis. Circ Res. 2014;114:1640–60.
18. Anguille S, Smits EL, Lion E, van Tendeloo VF, Berneman ZN. Clinical use of dendritic cells for cancer therapy. Lancet Oncol. 2014;15:e257–67.
19. Dietel B, Muench R, Kuehn C, Kerek F, Steinkasserer A, et al. MCS-18, a natural product isolated from Helleborus purpurascens, inhibits maturation of dendritic cells in ApoE-deficient mice and prevents early atherosclerosis progression. Atherosclerosis. 2014;235:263–72.
20. Dubrot J, Duraes FV, Potin L, Capotosti F, Brighouse D, et al. Lymph node stromal cells acquire peptide-MHCII complexes from dendritic cells and induce antigen-specific CD4+ T cell tolerance. J Exp Med. 2014;211:1153–66.
21. Shi W, Li X, Porter JL, Ostrodi DH, Yang B, et al. Level of plasmacytoid dendritic cells is increased in non-small cell lung carcinoma. Tumour Biol. 2014;35:2247–52.
22. Green TL, Santos MF, Ejaeidi AA, Craft BS, Lewis RE, et al. Toll-like receptor (TLR) expression of immune system cells from metastatic breast cancer patients with circulating tumor cells. Exp Mol Pathol. 2014;97:44–8.
23. Tel J, Hato SV, Torensma R, Buschow SI, Figdor CG, et al. The chemotherapeutic drug oxaliplatin differentially affects blood DC function dependent on environmental cues. Cancer Immunol Immunother. 2012;61:1101–11.
24. Troegeler A, Lastrucci C, Duval C, Tanne A, Cougoule C, et al. (2014) An efficient siRNA-mediated gene silencing in primary human monocytes, dendritic cells and macrophages. Immunol Cell Biol.